A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier

A Toll-like Receptor-Activating, Self-Adjuvant Glycan Nanocarrier

The global pandemic of COVID-19 highlights the importance of vaccination, which remains the most efficient measure against many diseases. Despite the progress in vaccine design, concerns with suboptimal antigen immunogenicity and delivery efficiency prevail. Self-adjuvant carriers–vehicles that can...

Full description

Bibliographic Details
Main Authors: Daping Xie, Yiming Niu, Ruoyu Mu, Senio Campos de Souza, Xiaoyu Yin, Lei Dong, Chunming Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Chemistry
Subjects:
polysaccharides
toll-like receptors
self-adjuvant
glucomannan
vaccination
Online Access:https://www.frontiersin.org/articles/10.3389/fchem.2022.864206/full

Internet

https://www.frontiersin.org/articles/10.3389/fchem.2022.864206/full

Similar Items